Biophysical characterization of DNA aptamer interactions with vascular endothelial growth factor
暂无分享,去创建一个
George W. Jackson | Katerina Kourentzi | R. Willson | K. Kourentzi | Han Fang | Ajish S. R. Potty | Richard C. Willson | G. Legge | Ajish S. R. Potty | George W. Jackson | Xing Zhang | Glen B. Legge | Xing Zhang | Han Fang
[1] P. D. de Jong,et al. Increased expression of angiogenic growth factors in age-related maculopathy , 1997, The British journal of ophthalmology.
[2] D. Guyer,et al. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease , 2006, Nature Reviews Drug Discovery.
[3] Victor Okhonin,et al. Selection of smart aptamers by methods of kinetic capillary electrophoresis. , 2006, Analytical chemistry.
[4] P. Romaniuk,et al. Characterization of RNA aptamer binding by the Wilms' tumor suppressor protein WT1. , 2001, Biochemistry.
[5] Michael R. Green,et al. HIV-1 rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA , 1991, Cell.
[6] J. Witz. Kinetic analysis of analyte binding by optical biosensors: hydrodynamic penetration of the analyte flow into the polymer matrix reduces the influence of mass transport. , 1999, Analytical biochemistry.
[7] S. Nishikawa,et al. Novel Approach to Analyzing RNA Aptamer-Protein Interactions: Toward Further Applications of Aptamers , 2006, Journal of biomolecular screening.
[8] G. Másson,et al. Determination of active concentrations and association and dissociation rate constants of interacting biomolecules: an analytical solution to the theory for kinetic and mass transport limitations in biosensor technology and its experimental verification. , 2002, Biochemistry.
[9] J. SantaLucia,et al. The thermodynamics of DNA structural motifs. , 2004, Annual review of biophysics and biomolecular structure.
[10] T. Lohman,et al. Ion effects on ligand-nucleic acid interactions. , 1976, Journal of molecular biology.
[11] O. Uhlenbeck,et al. Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. , 1987, Nucleic acids research.
[12] R K Jain,et al. Fluorescence photobleaching with spatial Fourier analysis: measurement of diffusion in light-scattering media. , 1993, Biophysical journal.
[13] D. Myszka,et al. Improving biosensor analysis , 1999, Journal of molecular recognition : JMR.
[14] A. Minton,et al. Analysis of mass transport-limited binding kinetics in evanescent wave biosensors. , 1996, Analytical biochemistry.
[15] P. V. von Hippel,et al. Facilitated Target Location in Biological Systems* , 2022 .
[16] Neal W. Woodbury,et al. Exploring the sequence space of a DNA aptamer using microarrays , 2007, Nucleic acids research.
[17] T. Fitzwater,et al. Potent 2′-amino-, and 2′-fluoro-2′- deoxyribonucleotide RNA inhibitors of keratinocyte growth factor , 1997, Nature Biotechnology.
[18] J. Szostak,et al. In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.
[19] D G Myszka,et al. Extending the range of rate constants available from BIACORE: interpreting mass transport-influenced binding data. , 1998, Biophysical journal.
[20] M. Siddiqui,et al. Pegaptanib , 2012, Drugs.
[21] Kazunori Ikebukuro,et al. Aptamer selection based on inhibitory activity using an evolution-mimicking algorithm. , 2006, Biochemical and biophysical research communications.
[22] Giridharan Gokulrangan,et al. DNA aptamer-based bioanalysis of IgE by fluorescence anisotropy. , 2005, Analytical chemistry.
[23] N. Janjić,et al. Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. , 1999, The American journal of pathology.
[24] A. D. de Vos,et al. Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[25] A. Varki,et al. DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice. , 1996, The Journal of clinical investigation.
[26] C. Milstein,et al. Conformational isomerism and the diversity of antibodies. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[27] A D Ellington,et al. Toward Automated Nucleic Acid Enzyme Selection , 2001, Biological chemistry.
[28] A. D. de Vos,et al. Crystal structure of the complex between VEGF and a receptor-blocking peptide. , 1998, Biochemistry.
[29] I. Tinoco,et al. How RNA folds. , 1999, Journal of molecular biology.
[30] E. Vermaas,et al. Selection of single-stranded DNA molecules that bind and inhibit human thrombin , 1992, Nature.
[31] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[32] J. Janin. The kinetics of protein‐protein recognition , 1997, Proteins.
[33] J. Szostak,et al. Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures , 1992, Nature.
[34] Napoleone Ferrara,et al. Vascular endothelial growth factor: basic science and clinical progress. , 2004, Endocrine reviews.
[35] Michael Zuker,et al. Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..
[36] Bing Li,et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.
[37] S. Titolo,et al. Characterization of the DNA-Binding Properties of the Origin-Binding Domain of Simian Virus 40 Large T Antigen by Fluorescence Anisotropy , 2003, Journal of Virology.
[38] T. Lohman,et al. Na+ effects on transitions of DNA and polynucleotides of variable linear charge density , 1976, Biopolymers.
[39] Susan M Lea,et al. Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1. , 2005, RNA.
[40] Jean Sturm,et al. Persistence Length of Single-Stranded DNA , 1997 .
[41] R. Willson,et al. Association and dissociation kinetics of anti-hen egg lysozyme monoclonal antibodies HyHEL-5 and HyHEL-10. , 1998, Biophysical journal.
[42] L. Christensen. Theoretical analysis of protein concentration determination using biosensor technology under conditions of partial mass transport limitation. , 1997, Analytical biochemistry.
[43] R. Rich,et al. Survey of the year 2004 commercial optical biosensor literature , 2005, Journal of molecular recognition : JMR.
[44] R W Glaser,et al. Antigen-antibody binding and mass transport by convection and diffusion to a surface: a two-dimensional computer model of binding and dissociation kinetics. , 1993, Analytical biochemistry.
[45] L. Gold,et al. RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[46] Shi-jie Chen,et al. Nucleic acid helix stability: effects of salt concentration, cation valence and size, and chain length. , 2006, Biophysical journal.
[47] J. Clark,et al. Novel non-templated nucleotide addition reactions catalyzed by procaryotic and eucaryotic DNA polymerases. , 1988, Nucleic acids research.
[48] Michael Musheev,et al. Non-SELEX selection of aptamers. , 2006, Journal of the American Chemical Society.
[49] J. SantaLucia,et al. A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[50] Christy F Landes,et al. Dynamics of an anti-VEGF DNA aptamer: a single-molecule study. , 2008, Biochemical and biophysical research communications.
[51] A. Pardi,et al. A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[52] P. Stockley,et al. Probing the kinetics of formation of the bacteriophage MS2 translational operator complex: identification of a protein conformer unable to bind RNA. , 2001, Journal of molecular biology.
[53] P. Richardson,et al. An improved method for the in vitro evolution of aptamers and applications in protein detection and purification. , 2003, Nucleic acids research.
[54] Charles Eigenbrot,et al. Crystal Structure at 1.7 Å Resolution of VEGF in Complex with Domain 2 of the Flt-1 Receptor , 1997, Cell.
[55] N. Janjić,et al. Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor. , 1994, Biochemistry.